The interval from the last cycle of docetaxel-based chemotherapy to progression is associated with the efficacy of subsequent docetaxel in patients with prostate cancer
| Image |  |
|---|---|
| Description | scientific article published on 17 May 2010 |
| Author/s |
author: Bernard Escudier Karim Fizazi |
| Publication date | May 17, 2010 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |